Watch Ticker

PMV Pharmaceuticals, Inc

Go to PMV Pharmaceuticals, Inc Website

$1.51

0.03 (2.03%)

Live

Previous Close

$1.48

Day Range

$1.44 - $1.52

Previous Day Range

$1.38 - $1.5195

Market Cap

$76.9 million USD

Day Vol.

161142

Previous Day Vol.

142728

Currency

USD

Primary Exchange

Nasdaq

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, r...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher

PMV Pharmaceuticals (PMVP) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Related tickers: PMVP.

Read Full Article

PMV Pharmaceuticals, Inc. - Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator

BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ: PMVP; “PMV Pharma”) today announced a partnership to develop Foundation Medicine’s tissue-based comprehensive genomic profiling test, FoundationOne®CDx, as a companion diagnostic for PMV Pharma’s rezatapopt, a first-in-class, investigational therapy for patients with locally advanced or metastatic solid tumors that have a TP53 Y220C mutation.

Related tickers: PMVP.

Read Full Article

Trending Tickers

Please sign in to view